Synergenetics Bioscience Inc. — Form D
Synergenetics Bioscience Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2020-03-30. The offering totals $100K, of which $100K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-03-30
- Form: D
- Accession: 0001085037-20-000018
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $100K
- Amount sold: $100K
- Investors: 1
- Date of first sale: 2020-03-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-363878
Issuer
- Name: Synergenetics Bioscience Inc.
- CIK: 0001800452
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Incorporated: 2019
- Address: 11001 GRANVILLE AVENUE, VANCOUVER, A1, V6Y 1R7
- Phone: 6047735180
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Ling Zhang | Director | Richmond, A1 |
| Ping Zhang | Director | Vancouver, A1 |
| Chong Chen | Executive Officer | Richmond, A1 |
| Ling Zhang | Executive Officer | Richmond, A1 |
| Ping Zhang | Executive Officer | Vancouver, A1 |
| Chong Chen | Director | Richmond, A1 |
| Cong Chen | Director | Richmond, A1 |
| Cong Chen | Executive Officer | Richmond, A1 |
Other filings by this issuer (2)
More